Interleukin 18 (IL-18) is a cytokine that plays an important role in the Th1 response, by its ability to induce IFN-c production in T cells and natural killer cells. Functional variants of IL18 gene has been reported as associated with type 1 diabetes (T1D). In the present study were analyzed three promoter single nucleotide polymorphisms (SNPs), at À656 (rs1946519), À607 (rs1946518) and À137 (rs187238) position, in 181 children and adolescents with T1D and 122 healthy individuals, both from metropo litan area of Recife, Northeast of Brazil. T1D patients were stratified accordin g to the presence autoimmune thyroiditis and celiac disease. Allele and genotype frequencies of IL18 SNPs were Hardy-Weinberg equilibrium in patients and controls. The allele À137G and the haplotype À656G/À607C/ À137G were more frequent in T1D patients (OR = 1.82 and 1.97, respectively) then in healthy controls. However, those SNPs were not associated with the age of T1D onset as well as with the insurgence of AITD and/or CD in concomitant with T1D patients. Our findings suggest an association between IL18 promoter SNPs and suscepti bility to T1D in Bra zilian patients.
Introduction
Type 1 diabetes mellitus (T1D) is a complex multifactorial disorder where pancreatic insulin producer beta cells are immunologically destroyed through a genetic and environmental interplay [1] . Moreover, during the chronic disease evolution of T1D, some patients could develop other organ-specific autoimmune events including the insurgen ce of autoimmune thyroidit is (AITD) and/ or celiac disease (CD) [2] [3] [4] , suggesting a shared pathogen esis pathway for these disorders.
The inflammatory pathway has an important role in the development and complicati ons of T1D [5] . In inflammations events, several interleukins (ILs) could be produced in order to activate specifics immune components and present itself as a potential factor in association to T1D pathogenesis [6] [7] [8] .
The pro-inflammatory interleukin 18 (IL-18) is directly involved in the innate and specific immune response, due to its ability to activate monocytes, macrophages , natural killer (NK) and in synergy with IL-12, to promote Th1 type response [8, 9] .
Single nucleotide polymorphis ms (SNPs) located at promote r position À607 (dbSNP: rs1946518) and À137 (dbSNP: rs187238) of IL18 gene (11q22.2-q23.3), involved in the decrease of IL18 expression [10] [11] [12] , have been studied and associated with the developmen t of T1D [11] [12] [13] . However , divergent results of association have been found in different populations, being necessary replicatio ns studies in population with different genetic background .
The aim of this work is to investiga te the association between IL18 promote r polymorphis ms, namely-656 (dbSNP: rs1946519), À607 (rs1946518) and À137 (rs187238), and T1D in a population from Northeast of Brazil. This genetic association was never performed in an admixtur e population, such the Brazilian one, additionally, we hypothesize that patient carrying the IL18 SNPs possess a lower risk to the insurgence of AITD and/or CD in concomitance with T1D, since low levels of IL-18 could diminish the Th1 response and the production of INF-c.
Materials and methods

Patients
T1D patients (n = 181) were enrolled and followed up at the three major pediatric endocrinolo gy centers of health public [14] . The mean age of T1D patients was 13.2 years (SD ± 4.1), with 101/181 (56%) females, a gender ratio equals to 1.26:1. The average age at the onset of T1D was 7.3 years (SD ± 3.4) and the mean duration of the disease was 5.9 years (SD ± 3.8).
Autoimmune thyroid and celiac disease diagnosis
Antibodies to thyroperox idase (Anti-TPO) diagnosis were performed by chemio-lumines cence (Immulite anti-TPO Ab, Diagnostic products Co., Los Angeles, USA). Patients with positive anti-TPO (titer exceedin g 35 IU/ml, accordingly to manufac turer's suggestion) were considered as having AITD.
Anti-transgl utaminase antibodies (anti-tTg) were determined by using the ELISA Eu-tTG kit (Eurospital, Trieste, Italy) following manufactur es instructions. Patients presenting 10 AU (absorbance units) for anti-tTg antibodies were considered positive and subsequently screened for the presence of HLA DQ2 and/or DQ8 HLA haplotypes by using the Eu-DQ kit (Eurospital, Trieste, Italy). After gluten-free diet in all CD patients, the tTG autoantib odies levels declined, remaining under the cutoff value of 7 AU.
The frequency of AITD in the T1D patients (T1D + AIDT + DCÀ) was 20.9% (38/181), the percentage of patients with CD (T1D + AIDT ÀDC+) was 5.5% (10/181), while patients characterized by both AITD and CD (T1D + AIDT + DC+) were 3.3% (6/181).
Healthy subjects
Healthy individuals from the same geographi cal region of patients group with no clinical evidence or family history of autoimmune diseases were included as control group. We enrolled 142 healthy subjects, mean age 21.4 years (SD ± 2.4), 93/142 (65%) females, a gender ratio 1.89:1. In the choice of the control population, the presence of any HLA possibly associated with celiac disease, AIDT, T1D and a titer exceeding 35 IU/ml for anti-TPO , 10 AU for anti-tTg and 40 nU/ml for anti-IAA were an exclusion criterion.
A free and informed consent from each person responsib le for the patient and healthy individuals were obtained. The local ethical committee (IMIP number 1717/2010) approved the study.
DNA extraction
Genomic DNA was extracted from peripheral whole blood using the Wizard genomic DNA purification kit (Promega, Madison, MA) according to the standard laborator y protocols.
SNP genotyping and haplotypes reconstru ction
The SNPs À656 C/A (rs1946519), À607 G/T (rs1946518) and À137 G/C (rs187238) located at promoter region of IL18 gene were genotyped using fluorescent allele-specific probes (TaqMan Ò , Life) with ABI-7500 Real-Time as platform. Linkage disequilibriu m and haplotypes were computed using the Arlequin software (version 3.1) and SNPstats (http://bioinfo.iconcologia.net/SN Pstats ).
Statistical analysis
Allele and genotype frequencies of IL18 promoter SNPs were obtained by direct counting. Fisher's exact test was used to correlate SNPs distribut ion and the increased susceptibility, clinical aspects of T1D and Hardy-Weinberg equilibrium were obtained using the R program (2005; version 2.1.1; http://www.r-project.org/ ).
Kruskal Wallis test was used in the age at diagnoses analyses. The power test analysis was performed through the GÃPower (version 3.1). Odds Ratio (OR) and 95% Confidence Intervals (CI) were also calculated. The p-values < 0.0015 was considered as statistically significant after Bonferroni correction for multiple tests.
Results
In this work we analyzed three functional polymorphi sms, À656 C/A, À607 G/T and À137 G/C, at promoter region of the IL18 gene in 181 T1D patients and 122 healthy subjects from the metropo litan region of Recife (Brazil). SNPs allele and genotype distribut ion are listed in Table 1 . Genotype and allele SNPs frequencies in the studied groups were in Hardy-Weinberg equilibriu m.
Thirty-thr ee analyses were done and six statistical differenc es were found. However, after Bonferroni Multiple Test Correction only two associations for the À137 SNP remained statistical ly significant (p > 0.0015). The À137G allele was less frequent in healthy subjects than in T1D + AITD À CDÀ (OR = 1.82, p = 0.0015; 95%CI = 1.24-2.69) and when compare d with all T1D + patients (p = 0.0001; OR = 1.96 95%CI = 1.37-2.80). In addition, the À137G/ G genotype was also statistically less frequent in healthy individuals than in patients T1D + AITD À CDÀ (p = 0.0005 OR = 4.55 95%CI = 1.77-12.9) and in T1D+ (p = 0.00004 OR = 5.00 95%CI = 2. 13-12.4) .
No association was found with the IL18 promoter polymorphism and the age at diagnosis of T1D.
Eight haplotypes were found in our population as showed in Table 2. The haplotypes À656G/À607C/À137G, À656T/À607A/À137C and À656T/À607A/À137G represent more than 80% of all haplotypes in the studied populations , the other five ones were rare. All SNPs were in linkage disequilibrium (D 0 > 0.8) in all groups, excluding the À656 and À137 SNPs in the TD1 + AITD + DC + and healthy groups (D 0 = 0.6).
The haplotype À656G/À607C/À137G and À656T/À607A/À137C were different ially distribut ed in case subjected when compare d with healthy individuals (p < 0.0000007).
Discussions
T1D is an autoimmune disorder resulted by initial infiltration of Th1 and Th2 lymphocy tes in pancreatic islet followed by progressive destruction of beta-cells [15, 16] . The predominance of Th1 response is widely associate d with T1D onset due to a higher production of interferon-c (INF-c) [17] . However, genetic studies on INF-c listed some rare variants with low phenotypic impact [18] , suggestin g other genetic approaches on the regulation of INF-c production by the IL-18 pathway in synergy with IL-12. In fact, IL-18 was originally named as an INF-c-inducing factor with a correlation between genetic SNP at promoter site of IL18 and INF-c production and T1D developmen t [10] .
The À607A and À137C SNPs are known to down-regul ate the gene expression of IL18 at the transcriptio nal level by disrupting the cAMP-re sponsive element-binding site and by changing the H4TF-1 nuclear factor binding at IL18 promoter [10] . Both events could influence, at least in part, the INF-c production.
In the present report, the allele À137G and genotype À137GG were associated with the susceptibi lity to T1D. In addition, the haplotype À656G/À607C/À137G was more frequent in case subjects. Both results supported the hypothesis that lower levels of IL-18 are protective to T1D onset. Several findings have been supporting that increased levels of IL-18 are associated with the susceptibilit y to T1D. The plasma levels of IL-18 in T1D patients are increased in subclinical stage and involved with disease progression [17, 19] . Moreove r, NOD mice with IL-18 deficiency are protected of T1D progression, since they exhibit reduced T cell turnover and fewer effectors T cell [11, 20] .
However, the contributi on of genetic variation at IL18 promoter on T1D onset remains on debate. Kretowski et al. [11] , in a Polish population, described that the À137GC genotypes in combination with À607AA gene was associated with susceptibility to T1D, but noted an increase in the frequency of À137C allele in T1D patients. In Chinese Han and Japanese populations the À607C alleles and À607CA genotype, respectivel y, and the haplotypes À607C/ À137G were more frequently in T1D patients [12, 13] . These data are according with the present report.
In contrast, independen t association studies performed in Iranian, Czech and England populations did not find association of IL18 promote r SNPs with the susceptibi lity to T1D [21] [22] [23] [24] . Moreover, a recent meta-analysis study of the SNP À607 CA, using several autoimm une disorder, reported no correlation with diabetes onset [25] . As well no association was found with the insurgence of AITD and CD in T1D patients, suggesting that the inflammatory pathway triggered by IL-18 are not shared in these disorder.
The pathogenesis of autoimmune diabetes is complex and not influenced only by genetic profile, but environmental factors could play an important role. As Dong et al. [12] observed the genetic pool diversity and different environm ental conditions might contribute to achieve opposite results in different populations of IL18 association.
In summary, our results showed an association of the À137G SNP at promote r of IL18 with the susceptibility to develop T1D in Brazilian patients. Brazilian individua ls from Northeast who carry this allele are more than 1.8 times more susceptible to T1D onset (OR = 1.82 95%CI = 1.24-2.69) and almost 2.0 times more if they carry the haplotype À656G/À607C/À137G (OR = 1.97 IC95% 1.31-2.97). However, those SNPs are not involved with the age at T1D diagnose and the insurgen ce of AITD and/or CD in concomitan t with T1D patients. It is important to note that after T1D patients' subgroup ing some subclasses remain very small, presenting wide confidence intervals. The a priori power test indicated that according to the SNP frequencies the sample size in each subclass were reliable to ensure the statistically significant results with power up to 95%. However, further robust analysis must be performed to increase the numbers of sample and diminish the effect of sam- Table 1 Interleukin 18 polymorphism s genotypes and allele frequencies of diabetes mellit us type 1 patients stratified according to the insurgence of autoimmune thyroid (AITD) and celiac disease (CD).
T1D + AITD + CD+
T1D + AITD + CDÀ T1D + AITD À CD+ T1D + AITD À CDÀ T1D+ Healthy n = 6 (%) n = 38 (%) n = 10 (%) n = 127 (%) n = 181 (%) n = 122 (%) Associations according to SNP position: Comparison Associated allele Associated genotype À656 T1D + AITD À CDÀ vs healthy T: p = 0.02 OR = 0.66 95%CI = 0.45-0.95 T/T: p = 0.02 OR = 0.38 95%CI = 0.16-0.88 T1D + vs healthy T: p = 0.03 OR = 0.69 95%CI = 0.49-0.97 T/T: p = 0.02 OR = 0.44 95%CI = 0.20-0.93 À137 T1D + AITD + CDÀ vs healthy G: p = 0.01 OR = 2.04 95%CI = 1.13-3.78 G/G: p = 0.01 OR = 5.83 95%CI = 1.23-55.9 T1D + AITD À CD + vs healthy G: p = 0.003 OR = 6.99 95%CI = 1.61-63.5 G/G: p = 0.017 OR = 5.61 95%CI = 1.04-56.93 T1D + AIDT À CDÀ vs healthy G: p = 0.0015 OR = 1.82 95%CI = 1.24-2.69 G/G: p = 0.00051 OR = 4.55 95%CI = 1.77-12.9 T1D + vs healthy G: p = 0.00012 OR = 1.96 95%CI = 1.37-2.80 G/G: p = 0.00004 OR = 5.00 95%CI = 2.13-12.4 Table 2 The haplotype distribution of interleuk in 18 polymorphism s, at -656/-607/-137 promoter position, in diabetes mellitus type 1 patients stratified according to the insurgence of autoimmune thyroid (AITD) and celiac disease (CD). Associations found: Comparison Haplotype À656T/À607A/À137C À656G/À607C/À137G T1D + AITD À DC + vs healthy OR = 1 p = 0.01 OR = 5.70 IC95%1.23-53.5 T1D + AITD À DCÀ vs healthy OR = 1 p = 0.0010 OR = 2.02 IC95% 1.3-3.15 T1D + vs healthy OR = 1 p = 0.0005 OR = 1.97 IC95% 1.31-2.97 ple size in order to expand the knowledge of IL18 variations on T1D developmen t and the insurgen ce of others autoimmune disorders.
Haplotypes
